NCT05749770View on ClinicalTrials.gov

Hormonal Contributors to COVID-19 Infection (COV-ENDO)

CompletedOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

June 30, 2024

Conditions
COVID-19 PandemicEndocrine System Diseases
Interventions
OTHER

blood testing

blood testing for basal hormones and markers of inflammation

Trial Locations (1)

20145

Istituto Auxologico Italiano IRCCS, Milan

All Listed Sponsors
lead

Istituto Auxologico Italiano

OTHER

NCT05749770 - Hormonal Contributors to COVID-19 Infection (COV-ENDO) | Biotech Hunter | Biotech Hunter